Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME659D
  • |
  • Pages: 280
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Johnson & Johnson (J&J) researches and develops, and manufactures and sells a range of pharmaceutical products, medical devices and consumer products. The company provides pharmaceuticals for immune diseases, cancer, neurological disorders, infectious, cardiovascular and metabolic diseases; consumer products in baby care, oral care, beauty, over-the-counter (OTC) pharmaceutical, women's health and wound care categories; and medical devices for use in the cardiovascular, orthopedic, surgery, diabetes care and vision care fields. J&J distributes pharmaceutical and medical products to retailers, wholesalers, health care professionals and hospitals; and offers consumer products through retail outlets and distributors. The company offers its products in the US; Europe; Asia-Pacific and Africa; and Western Hemisphere (excluding the US). J&J is headquartered in New Brunswick, New Jersey, the US.

Johnson & Johnson (JNJ)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 8

List of Figures 10

Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12

Johnson & Johnson, Medical Equipment Deals By Type, 2012 to YTD 2018 13

Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14

Johnson & Johnson, Medical Equipment, Deals By Market, 2012 to YTD 2018 15

Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Johnson & Johnson, Medical Equipment, Deal Details 31

Asset Purchase 31

Johnson & Johnson May Sell its Sterilization Products Division for up to USD2 Billion 31

DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 32

Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To USD 62 Million 33

Venture Financing 34

OrthoSpin Raises USD3 Million in Financing 34

Cue Health Raises USD45 Million in Series B Venture Financing 35

Zebra Medical Vision Raises USD30 Million in Series C Financing 37

NeuroVision Imaging Raises USD11.2 Million in Series C Venture Financing 38

V-Wave Raises USD70 Million in Series C Financing 40

RefleXion Medical Raises USD100 Million in Series C Financing 42

DayTwo Raises USD12 Million in Series A Financing 44

Hyalex Orthopaedics Raises USD16 Million in Series A Financing 45

CartiHeal Raises USD18.3 Million in Venture Financing 46

Grail Raises USD914 Million in First Tranche of Series B Financing 47

Atlas Genetics Raises USD35 Million in Series D Financing 50

OrthoSpace Raises USD7 Million in Venture Financing 52

ReVision Optics Raises USD32 Million in Venture Financing 53

CVRx Raises USD57.7 Million in Series G Financing 55

RefleXion Medical Raises Additional USD6 Million in Series B Financing 57

WellDoc Raises USD7.5 Million in Extended Series B Financing 58

Cala Health Raises USD18 Million in Series A Financing Round 59

Inivata Raises USD45 Million in Series A Financing 61

V-Wave Raises USD28 Million in Venture Financing 63

CartiHeal Raises USD15 Million in Venture Financing Round 64

Atlas Genetics Raises USD20 Million in Series C Financing 65

La Lumiere Raises USD20 Million in Series B Venture Financing 67

NeuWave Medical Raises USD4.76 Million in Venture Financing 68

Inivata Raises USD6.5 Million in Venture Financing 69

Biocartis Raises USD85 Million in Venture Financing 70

PowerVision Raises USD30 Million in Series D Financing 71

Inspire Medical Systems Raises USD40 Million In Series E Financing 73

Torax Medical Raises USD 13.7 Million In Venture Financing 75

Biocartis Raises USD 40.5 Million In Series E Financing 76

CVRx Raises USD 42 Million In Series F Financing 78

ReVision Optics Raises USD 55 Million In Venture Financing 80

Cardiac Dimensions Raises USD 2.4 Million In Venture Financing 82

Nevro Raises USD 48 Million In Series C Financing 84

Biocartis Raises USD 44.7 Million In Series D Financing 86

Torax Medical Raises USD 30 Million In Series D Financing 88

NeuWave Medical Raises USD 14 Million In Series B Financing 90

Astute Medical Raises USD 40.4 Million In Series C Financing 91

Mitralign Raises USD 35 Million In Series D Financing 93

Direct Flow Medical Secures USD0.28 Million in Venture Funding 95

Coherex Medical Secures USD16.5 Million in Venture Funding 96

PowerVision Raises Additional USD 12.5 Million In Series C Venture Financing 97

Pronota Raises USD 4.8 Million In Series C Financing 99

Clarimedix Raises Financing From COSAT 101

Private Equity 102

Platinum Equity Acquires LifeScan from Johnson & Johnson for USD2.1 Billion 102

Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 103

Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 105

Partnerships 107

Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 107

Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 108

KFx Medical Enters into Licensing Agreement with DePuy Mitek 109

NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 110

Auris Health Enters into Agreement with NeuWave Medical 111

Fujirebio Enters into Agreement with Janssen Pharma 112

Johnson & Johnson Innovation and Johnson & Johnson Vision Care Enter into Partnership with Queensland University of Technology 113

Johnson & Johnson Innovation, Janssen Cilag Enter into Partnership with Queensland University of Technology 114

Johnson & Johnson Innovation and Janssen Pharma Enter into Partnership with MiRXES 115

Johnson & Johnson Vision Care Enters into Partnership with Narayana Nethralaya 116

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with MiNDERA 117

Genomic Health Enters into Research Agreement with Janssen Pharma 118

DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 119

DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 120

Adaptive Biotech Enters into Partnership with Janssen Biotech 121

Sebia Enters into Agreement with Janssen Biotech 122

Johnson & Johnson Enters into Research Agreement with Orthocell 123

Rest Devices Enters into Agreement with Johnson & Johnson Consumer 124

Aspect Biosystems Partners with DePuy Synthes 125

Karolinska Institutet Partners with Johnson & Johnson Companies 126

WellDoc Enters into Agreement with LifeScan 127

Codman Neuro Enters into Distribution Agreement with InNeuroCo 128

Materialise Enters into Distribution Agreement with DePuy Synthes 129

Johnson & Johnson Services Partners with HP 130

LifeScan Enters into Agreement with WellDoc 131

Biosense Webster Enters into Agreement with Northwestern University 132

Medos International Enters into Agreement with Rainbow Medical 133

Ethicon Endo-Surgery Enters into Agreement with HistoSonics 134

Janssen Pharma Enters into Agreement with Cue 135

Johnson & Johnson Forms Joint Venture with Google Life Sciences 136

DePuy Synthes Enters into Agreement with Radlink 138

Royal Philips Enters into Co-Development Agreement with Janssen Pharma 139

Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 140

Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 141

DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 142

Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 143

Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 144

Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 145

BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 146

Janssen Research & Development Enters into Research Agreement with MD Biosciences 147

DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 148

Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 149

Myriad Enters Into Research Agreement With Janssen Research & Development 150

DePuy Synthes Expands Co-Marketing Agreement With Brainlab 151

Coherex Medical Enters Into Distribution Agreement With Biosense Webster 152

Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 153

Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 154

OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 155

Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 156

Philips Enters Into Technology Integration Agreement With Biosense Webster 157

DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 158

Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 159

West Pharma Enters Into Co-Development Agreement With Janssen Biotech 160

Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 161

Insulet Enters Into Technology Integration Agreement With LifeScan 162

Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 163

Equity Offering 164

Sphere Medical Completes Private Placement Of Shares For USD 5 Million With Johnson & Johnson 164

Debt Offering 165

Johnson & Johnson Completes Public Offering Of Notes Due 2033 For USD 650 Million 165

Johnson & Johnson Completes Public Offering Of Notes Due 2018 For USD 600 Million 167

Johnson & Johnson Completes Public Offering Of Notes Due 2016 For USD 400 Million 169

Johnson & Johnson Completes Public Offering Of Notes Due 2023 For USD 550 Million 171

Johnson & Johnson Completes Public Offering Of Notes Due 2043 For USD 500 Million 173

Johnson & Johnson Completes Public Offering Of Notes Due 2016 For USD 800 Million 175

Asset Transactions 177

CeQur Acquires Assets from Calibra Medical 177

Syncona Acquires Surgical Platform from Janssen Biotech 178

Sinocare May Acquire Diabetes Care Business from Johnson & Johnson for up to USD4 Billion 179

Centinel Spine Acquires Prodisc Assets from DePuy Synthes 180

Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 181

Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 183

Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For USD 280 Million 184

Johnson & Johnson To Sell Distal Volar Radius System To Biomet 185

Acquisition 186

Johnson & Johnson Medical Acquires Emerging Implant Technologies from SHS Gesellschaft 186

Fortive to Acquire Advanced Sterilization Products from Ethicon US for USD2.8 Billion 187

Apsis Acquires Orthotaxy 189

Johnson & Johnson Medical to Acquire Surgical Process Institute 190

Johnson & Johnson Acquires Sightbox 191

Abbott Medical Optics Acquires TearScience 192

Johnson & Johnson Acquires Actelion for USD30 Billion 193

Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 195

Codman Neuro Acquires Neuravi 197

Ethicon Acquires Torax Medical 198

Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 199

Ethicon Endo-Surgery Acquires Megadyne Medical Products 201

Codman Neuro Acquires Pulsar Vascular 202

DePuy Orthopaedics Acquires BioMedical Enterprises 203

Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 204

Johnson & Johnson May Acquire Transenterix 206

Johnson & Johnson Consumer Acquires La Lumiere 207

Biosense Webster Acquires Coherex Medical 208

Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 209

DePuy Synthes Acquires Olive Medical 211

Johnson & Johnson Plans to Acquire Cardiovascular Company 212

ZOLL Medical Acquires CoAxia, Medical Device Company 213

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 215

Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 217

LifeScan Acquires Calibra Medical 218

Johnson & Johnson Completes Acquisition Of Synthes For USD 19.7 Billion 219

Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 221

Johnson & Johnson - Key Competitors 222

Johnson & Johnson - Key Employees 223

Johnson & Johnson - Locations And Subsidiaries 224

Head Office 224

Other Locations & Subsidiaries 224

Recent Developments 243

Strategy And Business Planning 243

Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for $2.1bn 243

Financial Announcements 244

Jul 17, 2018: Johnson & Johnson Reports 2018 Second-Quarter Results 244

Apr 17, 2018: Johnson & Johnson Reports 2018 First-Quarter Results 246

Jan 23, 2018: Johnson & Johnson Reports 2017 Fourth-Quarter Results 248

Oct 17, 2017: Johnson & Johnson Reports 2017 Third-Quarter Results 250

Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results 252

Apr 19, 2017: Johnson & Johnson reports Q1 2017 results 254

Apr 18, 2017: Johnson & Johnson Reports 2017 First-Quarter Results 256

Apr 18, 2017: Johnson & Johnson Q1 net earnings down 258

Jan 24, 2017: Johnson & Johnson Reports 2016 Fourth-Quarter Results 259

Corporate Communications 261

Jun 22, 2018: Johnson & Johnson Announces Retirement of Group Worldwide Chairman, Sandra E. Peterson 261

Jun 22, 2018: Johnson & Johnson Appoints Senior Leaders to Executive Committee 262

Mar 20, 2018: Dominic J. Caruso to Retire as Chief Financial Officer of Johnson & Johnson 263

Legal and Regulatory 264

Nov 16, 2017: Federal Jury Returns $247 Million Verdict in Defective Hip Implants Case 264

Nov 01, 2017: Decision Diagnostics CEO Offers Primary Update on Legal Proceedings, Potential Outcomes, History, and Synopsis on Its Strategic Suit Against J&J 265

Oct 04, 2017: U.S. Supreme Court Turns Back Appeal of $3.27 Million Ethicon Transvaginal Mesh Lawsuit Verdict, Bernstein Liebhard LLP Reports 266

Aug 07, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania, As Sixth Trial Kicks Off in Philadelphia, Bernstein Liebhard Reports 267

Jun 26, 2017: Ethicon Transvaginal Mesh Lawsuits Move Forward in Pennsylvania Mass Tort Program, As Court Schedules July Meeting, Bernstein Liebhard Reports 268

Government and Public Interest 269

Jun 05, 2018: Johnson & Johnson Announces Progress Toward Health for Humanity Goals 269

Product News 270

Apr 05, 2018: Johnson & Johnson Institute Adds Innovative Analytics-Based Learning Platform to Help Surgeons Improve Technical Skills and Clinical Outcomes Across a Range of Specialties 270

Feb 26, 2018: New Late-Breaking XARELTO (rivaroxaban) and INVOKANA (canagliflozin) Data to be Presented at the American College of Cardiology's Annual Scientific Session 271

Oct 31, 2017: Ethicon Showcases Leading Edge Solutions Beyond The O.R. To Empower Patients And Providers In Fight Against Obesity At ObesityWeek 2017 274

Sep 01, 2017: Ethicon Launches New Surgical Simulation Tool, 'Touch Surgery', Across EMEA 276

Other Significant Developments 277

Nov 03, 2017: Johnson & Johnson wins Contract for Medical Surgical Products 277

Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage, a Suite of Holistic, Insights-Driven Capabilities to Help U.S. Health Systems Navigate Value-Based Care 278

Jan 09, 2017: Johnson & Johnson Medical Devices Companies Launch CareAdvantage 279

Appendix 280

Methodology 280

About GlobalData 280

Contact Us 280

Disclaimer 280

List of Figures

Johnson & Johnson, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Johnson & Johnson, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12

Johnson & Johnson, Medical Equipment, Deals by Type, 2012 to YTD 2018 13

Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14

Johnson & Johnson, Medical Equipment, Deals by Market, 2012 to YTD 2018 15

List of Tables

Johnson & Johnson, Medical Equipment, Key Facts, 2017 2

Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Johnson & Johnson, Medical Equipment, Deals By Year, 2012 to YTD 2018 12

Johnson & Johnson, Medical Equipment Deals By Type, 2012 to YTD 2018 13

Johnson & Johnson, Medical Equipment, Deals By Region, 2012 to YTD 2018 14

Johnson & Johnson, Deals By Market, 2012 to YTD 2018 15

Johnson & Johnson, Medical Equipment, Deals Summary, 2012 to YTD 2018 17

Johnson & Johnson May Sell its Sterilization Products Division for up to USD2 Billion 31

DePuy Synthes Acquires Expandable Cage Technology from Interventional Spine 32

Ethicon Acquires Quill Intellectual Property From Angiotech Pharma For Up To USD 62 Million 33

OrthoSpin Raises USD3 Million in Financing 34

Cue Health Raises USD45 Million in Series B Venture Financing 35

Zebra Medical Vision Raises USD30 Million in Series C Financing 37

NeuroVision Imaging Raises USD11.2 Million in Series C Venture Financing 38

V-Wave Raises USD70 Million in Series C Financing 40

RefleXion Medical Raises USD100 Million in Series C Financing 42

DayTwo Raises USD12 Million in Series A Financing 44

Hyalex Orthopaedics Raises USD16 Million in Series A Financing 45

CartiHeal Raises USD18.3 Million in Venture Financing 46

Grail Raises USD914 Million in First Tranche of Series B Financing 47

Atlas Genetics Raises USD35 Million in Series D Financing 50

OrthoSpace Raises USD7 Million in Venture Financing 52

ReVision Optics Raises USD32 Million in Venture Financing 53

CVRx Raises USD57.7 Million in Series G Financing 55

RefleXion Medical Raises Additional USD6 Million in Series B Financing 57

WellDoc Raises USD7.5 Million in Extended Series B Financing 58

Cala Health Raises USD18 Million in Series A Financing Round 59

Inivata Raises USD45 Million in Series A Financing 61

V-Wave Raises USD28 Million in Venture Financing 63

CartiHeal Raises USD15 Million in Venture Financing Round 64

Atlas Genetics Raises USD20 Million in Series C Financing 65

La Lumiere Raises USD20 Million in Series B Venture Financing 67

NeuWave Medical Raises USD4.76 Million in Venture Financing 68

Inivata Raises USD6.5 Million in Venture Financing 69

Biocartis Raises USD85 Million in Venture Financing 70

PowerVision Raises USD30 Million in Series D Financing 71

Inspire Medical Systems Raises USD40 Million In Series E Financing 73

Torax Medical Raises USD 13.7 Million In Venture Financing 75

Biocartis Raises USD 40.5 Million In Series E Financing 76

CVRx Raises USD 42 Million In Series F Financing 78

ReVision Optics Raises USD 55 Million In Venture Financing 80

Cardiac Dimensions Raises USD 2.4 Million In Venture Financing 82

Nevro Raises USD 48 Million In Series C Financing 84

Biocartis Raises USD 44.7 Million In Series D Financing 86

Torax Medical Raises USD 30 Million In Series D Financing 88

NeuWave Medical Raises USD 14 Million In Series B Financing 90

Astute Medical Raises USD 40.4 Million In Series C Financing 91

Mitralign Raises USD 35 Million In Series D Financing 93

Direct Flow Medical Secures USD0.28 Million in Venture Funding 95

Coherex Medical Secures USD16.5 Million in Venture Funding 96

PowerVision Raises Additional USD 12.5 Million In Series C Venture Financing 97

Pronota Raises USD 4.8 Million In Series C Financing 99

Clarimedix Raises Financing From COSAT 101

Platinum Equity Acquires LifeScan from Johnson & Johnson for USD2.1 Billion 102

Carlyle Group Completes Acquisition of Ortho-Clinical Diagnostics from Johnson & Johnson for up to USD4 Billion 103

Welsh, Carson, Anderson & Stowe Acquires GetWellNetwork, Provider Of Interactive Patient Care Solutions 105

Saladax Biomedical Enters into Licensing Agreement with Janssen Pharma 107

Janssen Research and Development Enters into Licensing Agreement with Optibrium for StarDrop 108

KFx Medical Enters into Licensing Agreement with DePuy Mitek 109

NanoPass Technologies Enters Into Licensing Agreement With Janssen Pharma For MicronJet 110

Auris Health Enters into Agreement with NeuWave Medical 111

Fujirebio Enters into Agreement with Janssen Pharma 112

Johnson & Johnson Innovation and Johnson & Johnson Vision Care Enter into Partnership with Queensland University of Technology 113

Johnson & Johnson Innovation, Janssen Cilag Enter into Partnership with Queensland University of Technology 114

Johnson & Johnson Innovation and Janssen Pharma Enter into Partnership with MiRXES 115

Johnson & Johnson Vision Care Enters into Partnership with Narayana Nethralaya 116

Johnson & Johnson Innovation and Janssen Biotech Enter into Partnership with MiNDERA 117

Genomic Health Enters into Research Agreement with Janssen Pharma 118

DePuy Synthes Enters into Co-Marketing Agreement with JointPoint 119

DePuy Synthes Enters into Co-Marketing Agreement with Medical Enterprises Distribution 120

Adaptive Biotech Enters into Partnership with Janssen Biotech 121

Sebia Enters into Agreement with Janssen Biotech 122

Johnson & Johnson Enters into Research Agreement with Orthocell 123

Rest Devices Enters into Agreement with Johnson & Johnson Consumer 124

Aspect Biosystems Partners with DePuy Synthes 125

Karolinska Institutet Partners with Johnson & Johnson Companies 126

WellDoc Enters into Agreement with LifeScan 127

Codman Neuro Enters into Distribution Agreement with InNeuroCo 128

Materialise Enters into Distribution Agreement with DePuy Synthes 129

Johnson & Johnson Services Partners with HP 130

LifeScan Enters into Agreement with WellDoc 131

Biosense Webster Enters into Agreement with Northwestern University 132

Medos International Enters into Agreement with Rainbow Medical 133

Ethicon Endo-Surgery Enters into Agreement with HistoSonics 134

Janssen Pharma Enters into Agreement with Cue 135

Johnson & Johnson Forms Joint Venture with Google Life Sciences 136

DePuy Synthes Enters into Agreement with Radlink 138

Royal Philips Enters into Co-Development Agreement with Janssen Pharma 139

Mitsubishi Tanabe Enters into Co-Promotion Agreement with Johnson & Johnson K.K. 140

Abbott Medical Optics Enters into Distribution Agreement with Carl Zeiss Meditec 141

DePuy Synthes Enters into Co-Marketing Agreement with Blue Belt for Navio System 142

Codman & Shurtleff Enters into Distribution Agreement with Pulsar Vascular 143

Illumina Partners with AstraZeneca, Janssen and Sanofi to Develop NGS-Based Oncology Test System 144

Tissue Regeneration Systems Enters into Co-Development Agreement with DePuy Synthes Products and Johnson & Johnson Innovation 145

BrainStem Biometrics Systems Enters into Research Agreement with Ethicon Endo-Surgery 146

Janssen Research & Development Enters into Research Agreement with MD Biosciences 147

DePuy Orthopaedics Enters Into Licensing Agreement With LifeNet Health For Cellular Allograft Product 148

Adaptive Biotech Enters Into Biomarker Discovery Agreement With Johnson & Johnson Innovation 149

Myriad Enters Into Research Agreement With Janssen Research & Development 150

DePuy Synthes Expands Co-Marketing Agreement With Brainlab 151

Coherex Medical Enters Into Distribution Agreement With Biosense Webster 152

Janssen Pharmaceutica Enters Into Co-Development Agreement With Siemens Healthcare Diagnostics 153

Arno Therapeutics Enters Into Co-Development Agreement With Veridex For Diagnostic Test 154

OICR Enters Into Co-Development Agreement With Janssen For Prostate Cancer Biomarkers 155

Abbott Molecular Enters Into Agreement With Janssen Biotech And Pharmacyclics For Leukemia Test 156

Philips Enters Into Technology Integration Agreement With Biosense Webster 157

DePuy Spine Enters Into Integration Agreement With Brainlab For Surgical And Imaging Solutions 158

Abbott Medical Optics and ShapeTech Partner To Develop New Polymers For Intraocular Lenses 159

West Pharma Enters Into Co-Development Agreement With Janssen Biotech 160

Biosense Webster Enters Into Technology Integration Agreement With GE Healthcare Systems And Siemens Healthcare 161

Insulet Enters Into Technology Integration Agreement With LifeScan 162

Biosense Webster Enters Into Distribution Agreement With GE Healthcare Systems 163

Sphere Medical Completes Private Placement Of Shares For USD 5 Million With Johnson & Johnson 164

Johnson & Johnson Completes Public Offering Of Notes Due 2033 For USD 650 Million 165

Johnson & Johnson Completes Public Offering Of Notes Due 2018 For USD 600 Million 167

Johnson & Johnson Completes Public Offering Of Notes Due 2016 For USD 400 Million 169

Johnson & Johnson Completes Public Offering Of Notes Due 2023 For USD 550 Million 171

Johnson & Johnson Completes Public Offering Of Notes Due 2043 For USD 500 Million 173

Johnson & Johnson Completes Public Offering Of Notes Due 2016 For USD 800 Million 175

CeQur Acquires Assets from Calibra Medical 177

Syncona Acquires Surgical Platform from Janssen Biotech 178

Sinocare May Acquire Diabetes Care Business from Johnson & Johnson for up to USD4 Billion 179

Centinel Spine Acquires Prodisc Assets from DePuy Synthes 180

Integra LifeSciences Acquires Neurosurgery Business of Codman Neuro for USD1 Billion 181

Menarini-Silicon Biosystems Acquires Cellsearch CTC System from Janssen Diagnostics 183

Biomet Completes Acquisition Of Trauma Business Of Depuy Orthopaedics For USD 280 Million 184

Johnson & Johnson To Sell Distal Volar Radius System To Biomet 185

Johnson & Johnson Medical Acquires Emerging Implant Technologies from SHS Gesellschaft 186

Fortive to Acquire Advanced Sterilization Products from Ethicon US for USD2.8 Billion 187

Apsis Acquires Orthotaxy 189

Johnson & Johnson Medical to Acquire Surgical Process Institute 190

Johnson & Johnson Acquires Sightbox 191

Abbott Medical Optics Acquires TearScience 192

Johnson & Johnson Acquires Actelion for USD30 Billion 193

Johnson & Johnson, Novartis and Takeda Pharma May Acquire Hypermarcas 195

Codman Neuro Acquires Neuravi 197

Ethicon Acquires Torax Medical 198

Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 199

Ethicon Endo-Surgery Acquires Megadyne Medical Products 201

Codman Neuro Acquires Pulsar Vascular 202

DePuy Orthopaedics Acquires BioMedical Enterprises 203

Ethicon Acquires NeuWave Medical from H.I.G. BioHealth Partners 204

Johnson & Johnson May Acquire Transenterix 206

Johnson & Johnson Consumer Acquires La Lumiere 207

Biosense Webster Acquires Coherex Medical 208

Cardinal Health Acquires Cordis from Johnson & Johnson for USD1.94 Billion 209

DePuy Synthes Acquires Olive Medical 211

Johnson & Johnson Plans to Acquire Cardiovascular Company 212

ZOLL Medical Acquires CoAxia, Medical Device Company 213

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 215

Johnson & Johnson Acquires Spectrum Vision, Contact Lens Distributor 217

LifeScan Acquires Calibra Medical 218

Johnson & Johnson Completes Acquisition Of Synthes For USD 19.7 Billion 219

Johnson & Johnson (China) Acquires Guangzhou Bioseal Biotech 221

Johnson & Johnson, Key Competitors 222

Johnson & Johnson, Key Employees 223

Johnson & Johnson, Subsidiaries 224

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Johnson & Johnson, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17980
Site License
USD 500 INR 35960
Corporate User License
USD 750 INR 53940

NEWSLETTER BY CATEGORY




Testimonials

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com